Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models-Reference-Cited by-同舟云学术

Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models

Published:2015-10-20 Issue: Volume:9 Page:
ISSN:1662-5153
Container-title:Frontiers in Behavioral Neuroscience
language:
Short-container-title:Front. Behav. Neurosci.

Author:

Souchet Benoit,Guedj Fayçal,Penke-Verdier Zsuza,Daubigney Fabrice,Duchon Arnaud,Herault Yann,Bizot Jean-Charles,Janel Nathalie,Créau Nicole,Delatour Benoit,Delabar Jean M.

Funder

Agence Nationale de la Recherche

Fondation Jérôme Lejeune

Association française pour la recherche sur la trisomie 21

Publisher

Frontiers Media SA

Subject

Behavioral Neuroscience,Cognitive Neuroscience,Neuropsychology and Physiological Psychology

Reference28 articles.

1. Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways;Adayev;Biochemistry,2006

2. The specificities of protein kinase inhibitors: an update;Bain;Biochem. J.,2003

3. The “Down syndrome critical region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome;Belichenko;J. Neurosci.,2009

4. Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice;Braudeau;J. Psychopharmacol.,2011

5. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats;Carta;Synapse,2002

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic effects of trisomy and pharmacologic modulation on structural, functional, molecular, and genetic systems in a Down syndrome mouse model;eLife;2024-03-18

2. EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model;European Journal of Medicinal Chemistry;2024-02

3. The Role of Oxidative Stress in Trisomy 21 Phenotype;Cellular and Molecular Neurobiology;2023-10-11

4. Pleiotropic effects of trisomy and pharmacologic modulation on structural, functional, molecular, and genetic systems in a Down syndrome mouse model;ELIFE;2023-10-06

5. Pleiotropic effects of trisomy and pharmacologic modulation on structural, functional, molecular, and genetic systems in a Down syndrome mouse model;2023-08-01